Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T16:36:36.458Z.
Calculation as of: 2026-10-06T16:36:36.458Z.
Quote observation: 2026-10-06T16:28:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 12cea9f103536ce45d7cd9f5ad4e572cb47010be1e9ba78d50bf2d4cf37a5898
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$45.20M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.31M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.42M
Price/FCF Ratio
10.23
TTM Avg
33.81
3Y Avg
4688.00
5Y Avg
4688.00
Market Cap
$47.83M
Price/FCF Ratio
N/A
TTM Avg
99.30
3Y Avg
99.30
5Y Avg
93.30
Market Cap
$42.29M
Price/FCF Ratio
N/A
TTM Avg
19.80
3Y Avg
20.69
5Y Avg
119.64
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DarioHealth Corp. (DRIO) | $45.37M | N/A | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $44.85M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.31M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.85M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $43.42M | 10.23 | 33.81 | 4688.00 | 4688.00 |
| Precision Optics Corporation, Inc. (POCI)vs › | $47.83M | N/A | 99.30 | 99.30 | 93.30 |
| Precipio, Inc. (PRPO)vs › | $41.92M | 53.13 | 75.00 | 61.77 | 61.77 |
| BioStem Technologies, Inc. (BSEM)vs › | $42.29M | N/A | 19.80 | 20.69 | 119.64 |
| Lite Strategy, Inc. (LITS)vs › | $49.00M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
